Next Capital Management LLC Vertex Pharmaceuticals Inc Transaction History

Next Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$166.71 - $223.91 $15,003 - $20,151	-90 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$166.23 - $187.09 $12,633 - $14,218	-76 Reduced 45.78%	90 $15,000
Q2 2019 Aug 02, 2019	BUY	$164.61 - $190.37 $12,510 - $14,468	76 Added 84.44%	166 $30,000
Q4 2018 Feb 12, 2019	BUY	$151.91 - $192.21 $13,671 - $17,298	90 New	90 $15,000

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Next Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Next Capital Management LLC with notifications on news.